Homozygous SLC34A3 Mutation With Heterozygous SLC34A1 Deletion Presenting as Chronic Kidney Disease and Medullary Nephrocalcinosis Without Skeletal Manifestations: A Case Report
Case Reports in Nephrology and Dialysis · 10.11.2026
DOI: 10.1159/cnd/abxag011 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Nephrology and Dialysis, online erschienen am 10.11.2026. Verfasst von Hasaan Salman Shafi und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) is a rare autosomal recessive, FGF23-independent phosphate-wasting disorder caused by pathogenic variants in SLC34A3, which encodes the renal sodium-phosphate cotransporter NaPi-IIc. Classically, HHRH is characterized by hypophosphatemia, elevated 1,25-dihydroxyvitamin D, hypercalciuria, nephrocalcinosis, and skeletal manifestations. Its recognition is important because management differs from FGF23-mediated hypophosphatemic disorders. Case Presentation: We report a 19-year-old male who was incidentally found to have hypertension and chronic kidney disease. Further evaluation revealed bilateral medullary nephrocalcinosis and initial hyperoxaluria, prompting genetic testing for suspected primary hyperoxaluria. Whole-exome sequencing instead identified a homozygous pathogenic frameshift variant in SLC34A3: NM_001177316.2.1247del, p.Leu416ProfsTer65, consistent with HHRH. An additional heterozygous likely pathogenic exon-level deletion involving SLC34A1 was also detected: NM_003052.5 deletion, which are a previously unreported combination of mutations. The patient had no clinical features of rickets, and DEXA scan showed no osteoporosis. Biochemical evaluation showed low-normal serum phosphate, elevated 1,25-dihydroxyvitamin D, and no marked hypercalciuria on available 24-hour urine collections. Repeat urinary oxalate decreased substantially after dietary modification, supporting a likely dietary contribution to the initial hyperoxaluria.
Conclusions
This case highlights an atypical renal-predominant presentation of SLC34A3-associated disease, with CKD and nephrocalcinosis in the absence of overt skeletal abnormalities. The coexistence of a likely pathogenic SLC34A1 deletion may have modified the phenotype, although this requires further confirmation through segregation or functional studies. To our knowledge, this specific combination of homozygous SLC34A3 mutation with heterozygous SLC34A1 deletion has not been previously reported.
Zitieren
APA
Shafi, H. S., Abidin, M. Z. U., & Ahmed, I. (2026). Homozygous SLC34A3 Mutation With Heterozygous SLC34A1 Deletion Presenting as Chronic Kidney Disease and Medullary Nephrocalcinosis Without Skeletal Manifestations: A Case Report. Case Reports in Nephrology and Dialysis. https://doi.org/10.1159/cnd/abxag011
Vancouver
Shafi HS, Abidin MZU, Ahmed I. Homozygous SLC34A3 Mutation With Heterozygous SLC34A1 Deletion Presenting as Chronic Kidney Disease and Medullary Nephrocalcinosis Without Skeletal Manifestations: A Case Report. Case Reports in Nephrology and Dialysis. 2026. doi:10.1159/cnd/abxag011
BibTeX
@article{Shafi2026,
author = {Shafi, Hasaan Salman and Abidin, Muhammad Zain Ul and Ahmed, Irfan},
title = {Homozygous SLC34A3 Mutation With Heterozygous SLC34A1 Deletion Presenting as Chronic Kidney Disease and Medullary Nephrocalcinosis Without Skeletal Manifestations: A Case Report},
journal = {Case Reports in Nephrology and Dialysis},
year = {2026},
doi = {10.1159/cnd/abxag011}
}
EUVIMED